Page last updated: 2024-11-11

(2-sulfonatoethyl)methanethiosulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

(2-sulfonatoethyl)methanethiosulfonate: RN given for Na salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID23688468
MeSH IDM0283357

Synonyms (8)

Synonym
(2-sulfonatoethyl)methanethiosulfonate
2-((methylthio)sulfonyl)ethanesulfonic acid sodium salt
mtses cpd
methanethiosulfonate ethylsulfonate
ethanesulfonic acid, 2-((methylthio)sulfonyl)-, sodium salt
sodium;2-methylsulfanylsulfonylethanesulfonate
J4SU48UKA9
ethanesulfonic acid, 2-[(methylthio)sulfonyl]-, sodium salt

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response analysis showed that treatment with MTSET increased the potency of the FMRFamide in the FaNaC whereas treatment with MTSES reduced the maximum response."( Electrostatic charge at position 552 affects the activation and permeation of FMRFamide-gated Na+ channels.
Furukawa, Y; Kodani, Y, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (85)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's10 (11.76)18.2507
2000's55 (64.71)29.6817
2010's20 (23.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other86 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]